Evidence map›Paper›PMID 31392209›Full record

ArticleBioMed research international2019

High Proliferative Placenta-Derived Multipotent Cells Express Cytokeratin 7 at Low Level.

V Shablii, M Kuchma, H Svitina, I Skrypkina, P Areshkov, V Kyryk, T Bukreieva, V Nikulina, Iu Shablii, G Lobyntseva

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

V ShabliiInstitute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, Kyiv, Ukraine.ORCID https://orcid.org/0000-0002-1058-7947
M KuchmaInstitute of Cell Therapy, Kyiv, Ukraine.
H SvitinaInstitute of Cell Therapy, Kyiv, Ukraine.ORCID https://orcid.org/0000-0003-4811-3787
I SkrypkinaInstitute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, Kyiv, Ukraine.ORCID https://orcid.org/0000-0003-0529-6069
P AreshkovInstitute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, Kyiv, Ukraine.ORCID https://orcid.org/0000-0002-6715-5352
V KyrykState Institute of Genetic and Regenerative Medicine of Academy of Medicine of Ukraine, Kyiv, Ukraine.ORCID https://orcid.org/0000-0001-7636-1302
T BukreievaInstitute of Cell Therapy, Kyiv, Ukraine.ORCID https://orcid.org/0000-0001-5647-1088
V NikulinaInstitute of Cell Therapy, Kyiv, Ukraine.ORCID https://orcid.org/0000-0002-6255-2148
Iu ShabliiInstitute of Cell Therapy, Kyiv, Ukraine.
G LobyntsevaInstitute of Cell Therapy, Kyiv, Ukraine.
Institute of Cell Biology · UANational Academy of Sciences of Ukraine · UAInstitute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine · UAMinistry of Health · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to investigate the immunophenotypes and gene expression profile of high proliferative placenta-derived multipotent cells (PDMCs) population at different stages of culture. We demonstrated that the colonies resulting from single cells were either positive or negative for CK7, whereas only PDMC clones with weak CK7 expression (CK7

Indexed as

Gene Expression RegulationAdultAntigens, DifferentiationCell ProliferationFemaleHumansKeratin-7Multipotent Stem CellsPlacentaPregnancyPregnancy ProteinsAntigens, DifferentiationKeratin-7Pregnancy Proteins

Identifiers

PMID31392209
PMCPMC6662495
OpenAlexW2960110515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.